Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte (Q34184706)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte |
scientific article |
Statements
1 reference
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte (English)
1 reference
Catherine Thieblemont
1 reference
Bertrand Coiffier
1 reference
Eric Van Den Neste
1 reference
Gérard Lepeu
1 reference
Isabelle Plantier
1 reference
Sylvie Castaigne
1 reference
Sophie Lefort
1 reference
Gérald Marit
1 reference
Margaret Macro
1 reference
Catherine Sebban
1 reference
Karim Belhadj
1 reference
Dominique Bordessoule
1 reference
Christophe Fermé
1 reference
Hervé Tilly
1 reference
14 June 2010
1 reference
1 reference
116
1 reference
12
1 reference
2040-2045
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference